CRISPR THERAPEUTICS AG (CRSP) Stock Cash Flow
NASDAQ:CRSP - Nasdaq - CH0334081137 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -385.66M | -366.25M | -153.61M | -650.20M | 377.70M | |||
| Depreciation Amortization | 19.16M | 19.26M | 19.84M | 24.20M | 18.00M | |||
| Change In Working Capital | 628.00K | 156.27M | -193.59M | 19.80M | 26.90M | |||
| Other non cash items | 59.39M | 47.95M | 66.98M | 110.40M | 116.50M | |||
| OPERATING CASH FLOW | -306.47M | -142.77M | -260.38M | -495.70M | 539.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.39M | -1.90M | -11.97M | -37.20M | -81.70M | |||
| Other Investing Activity | -201.05M | -278.58M | 386.62M | -221.50M | -953.70M | |||
| INVESTING CASH FLOW | -202.44M | -280.48M | 374.65M | -258.70M | -1.04B | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 36.64M | 331.98M | 62.66M | 38.60M | 250.90M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 36.64M | 331.98M | 62.66M | 38.60M | 250.90M | |||
| Exchange Rate Effect | 31.00K | -21.00K | 73.00K | -100.00K | 0.00 | |||
| CHANGE IN CASH | -472.24M | -91.29M | 177.01M | -715.90M | -245.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -306.47M | -142.77M | -260.38M | -495.70M | 539.00M | |||
| Capital Expenditure | -1.39M | -1.90M | -11.97M | -37.20M | -81.70M | |||
| FREE CASH FLOW | -307.86M | -144.68M | -272.35M | -532.90M | 457.30M | |||
All data in USD